BACKGROUND & AIMS: Previous studies have shown that gastric ulceration stimulates epithelial cell proliferation and overexpression of epidermal growth factor (EGF) and EGF receptor (EGF-R) in the mucosa bordering necrosis. The aim of this study was to investigate whether extracellular signal-regulated kinase (ERK) cascade is involved in the healing of experimental gastric ulcers. METHODS: We studied EGF-R levels, EGF-R phosphorylation levels, and ERK1 and ERK2 activity in normal and ulcerated rat gastric mucosa. We also examined the effect of Tyrphostin A46 (potent inhibitor of EGF-R and EGF-R kinase-dependent proliferation) on the above parameters. RESULTS: During the initial stages of healing (3 and 7 days), ulcerated mucosa showed significant increase (vs. controls) in protein tyrosine kinase activity, EGF-R levels (510% and 550%), EGF-R phosphorylation levels, ERK1 activity (430% and 880%), and ERK2 activity (550% and 990%). Tyrphostin A46 treatment significantly inhibited ulcer healing and reduced EGF-R levels, EGF-R phosphorylation, and ERK1 and ERK2 activity. CONCLUSIONS: These findings indicate that experimental gastric ulcer healing involves activation of EGF-R-ERK signal transduction pathway.
BACKGROUND & AIMS: Previous studies have shown that gastric ulceration stimulates epithelial cell proliferation and overexpression of epidermal growth factor (EGF) and EGF receptor (EGF-R) in the mucosa bordering necrosis. The aim of this study was to investigate whether extracellular signal-regulated kinase (ERK) cascade is involved in the healing of experimental gastric ulcers. METHODS: We studied EGF-R levels, EGF-R phosphorylation levels, and ERK1 and ERK2 activity in normal and ulcerated rat gastric mucosa. We also examined the effect of Tyrphostin A46 (potent inhibitor of EGF-R and EGF-R kinase-dependent proliferation) on the above parameters. RESULTS: During the initial stages of healing (3 and 7 days), ulcerated mucosa showed significant increase (vs. controls) in protein tyrosine kinase activity, EGF-R levels (510% and 550%), EGF-R phosphorylation levels, ERK1 activity (430% and 880%), and ERK2 activity (550% and 990%). Tyrphostin A46 treatment significantly inhibited ulcer healing and reduced EGF-R levels, EGF-R phosphorylation, and ERK1 and ERK2 activity. CONCLUSIONS: These findings indicate that experimental gastric ulcer healing involves activation of EGF-R-ERK signal transduction pathway.
Authors: James J Farrell; Douglas Taupin; Theodore J Koh; Duan Chen; Chun-Mei Zhao; Daniel K Podolsky; Timothy C Wang Journal: J Clin Invest Date: 2002-01 Impact factor: 14.808
Authors: K Mitsuyama; O Tsuruta; Y Matsui; K Harada; N Tomiyasu; A Suzuki; K Takaki; J Masuda; K Handa; Y Satoh; B L Bennett; A Toyonaga; M Sata Journal: Clin Exp Immunol Date: 2006-01 Impact factor: 4.330
Authors: Iyore A O James; Chun-Liang Chen; Guangcun Huang; Hong-Yi Zhang; Markus Velten; Gail E Besner Journal: J Surg Res Date: 2010-04-24 Impact factor: 2.192
Authors: Christopher P Gayer; Lakshmi S Chaturvedi; Shouye Wang; Brittany Alston; Thomas L Flanigan; Marc D Basson Journal: Am J Physiol Gastrointest Liver Physiol Date: 2009-01-29 Impact factor: 4.052
Authors: Rudolf A de Boer; Saraswati Pokharel; Markus Flesch; Derk A van Kampen; Albert J H Suurmeijer; Frans Boomsma; Wiek H van Gilst; Dirk J van Veldhuisen; Yigal M Pinto Journal: J Mol Med (Berl) Date: 2004-08-20 Impact factor: 4.599